Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $10.32 and traded as high as $10.42. Cipher Pharmaceuticals shares last traded at $10.24, with a volume of 27,932 shares trading hands.
Cipher Pharmaceuticals Stock Down 0.9 %
The company has a 50-day simple moving average of $10.32 and a two-hundred day simple moving average of $10.14.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.
Featured Stories
- Five stocks we like better than Cipher Pharmaceuticals
- 3 REITs to Buy and Hold for the Long Term
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What Are the FAANG Stocks and Are They Good Investments?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- About the Markup Calculator
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
